20-F/A: Zhibao Tech Subsidiary Joins Major China Health Insurance Consortium
Amendment to Annual Report (Form 20-F/A) and Cooperation Agreement
Sunshine Insurance Brokerage (Shanghai) Co., Ltd., a subsidiary of Zhibao Technology Inc., has entered a significant cooperation agreement to provide brokerage services for a large-scale inclusive commercial health insurance project in China.
Summary
- Sunshine Insurance Brokerage (Shanghai) Co., Ltd. (Party J), a Zhibao Technology Inc. subsidiary, is the insurance brokerage service provider for the "[] Project," an inclusive commercial health insurance scheme.
- The project involves a consortium of eight insurers (one Lead Insurer and seven Co-insurers) and a platform technical service provider, with their specific names redacted in the filing.
- The agreement, dated November 25, 2024, outlines the roles, responsibilities, co-insurance arrangements, technical services, and brokerage services for the project.
- The business objective for the third phase of the project is a guaranteed 8% participation rate (approximately 2.56 million people) and a targeted 10% (approximately 3.2 million people), based on a fundamental medical insurance participant base of 32 million people in an unspecified province (excluding an unspecified region).
- The insurance product, "[] 2025," has a uniform premium of RMB 149 per person per annum, with an enrolment period from November 20, 2024, to March 31, 2025, and a policy period from January 1, 2025, to December 31, 2025.
- Key coverage includes up to RMB 1 million for in-catalogue hospitalisation, RMB 2 million for out-of-catalogue hospitalisation, and RMB 10,000 for phenylketonuria expenses, with a deductible of RMB 45,000 (RMB 38,000 for first-time/claim-free renewals).
- Sunshine Insurance Brokerage will receive a brokerage commission of 10.6% of the full premium amount actually received by the co-insurers.
- The Lead Insurer is responsible for unified premium collection, policy issuance, claims settlement, and overall consortium management.
- Co-insurers are required to deposit a performance bond equivalent to an unspecified percentage of their final share of the premium.
- The filing also includes certifications from Zhibao Technology Inc.'s CEO, Botao Ma, and CFO, Yuanwen Xia, for the fiscal year ended June 30, 2025, affirming the accuracy of the annual report and effectiveness of internal controls.
Sentiment
Score: 7
Explanation: The filing details a significant new business cooperation agreement for a subsidiary, indicating positive strategic development and potential revenue streams. However, the lack of specific financial projections (beyond participation targets) and redacted partner names introduce some uncertainty, preventing a higher score.
Positives
- Secures a significant role for Zhibao Technology's subsidiary, Sunshine Insurance Brokerage, in a large-scale government-backed inclusive health insurance project.
- The project targets a substantial participant base of 2.56 million to 3.2 million people, indicating potential for significant premium generation and market penetration.
- Clear delineation of roles and responsibilities among the Lead Insurer, Co-insurers, technical service provider, and brokerage service provider aims to ensure efficient project execution.
- Standardized operational procedures, including unified decision-making, management, and claims settlement, are designed to streamline operations and reduce potential conflicts.
- The product design, "[] 2025," includes comprehensive coverage with no age or health restrictions, broadening market appeal and addressing a critical public need.
- The agreement includes robust clauses for consumer rights protection, data security, and anti-money laundering, enhancing trust and regulatory compliance.
Negatives
- Specific financial figures for the total contract value, technical service fees, and the exact percentage of the performance bond are omitted from the public filing, limiting a full financial assessment.
- The names of the Lead Insurer, Co-insurers, and Platform Technical Service Provider are redacted, limiting transparency regarding key partners and their market standing.
- The success of the project relies heavily on achieving ambitious participation rate targets (8-10% of 32 million basic medical insurance participants), which may pose a challenge.
- The agreement includes strict penalties for co-insurers failing to remit claims payments or withdrawing from the consortium, indicating potential for disputes and operational friction.
- Sales expenses are capped at 5% of the policy premium, which could limit aggressive marketing efforts or require careful cost management.
Risks
- Operational Risk: Failure to achieve the targeted participation rates of 8% to 10% (2.56 million to 3.2 million people) could impact revenue and profitability for the consortium members, including the brokerage service provider.
- Compliance Risk: Non-adherence to national insurance laws, regulations, anti-money laundering, anti-commercial bribery, consumer rights protection, and data security laws could lead to severe penalties, reputational damage, or termination of cooperation.
- Reputational Risk: Any conduct disrespectful, disparaging, or defamatory of other participating entities, or incidents detrimental to the "[] brand image," could harm the consortium's collective reputation and public trust.
- Financial Risk: Co-insurers failing to remit claims payments or other expenses in a timely manner, or exceeding the 5% sales expense limit, could lead to financial strain, penalties, or legal proceedings.
- Data Security Risk: Breaches, alterations, or loss of customer personal information could result in significant legal liability, financial penalties, and severe reputational damage.
- Competition Risk: Unfair competition practices among co-insurers, such as inciting policyholders to cancel and re-enrol through their own channels, could disrupt market order and lead to consortium instability.
- System Errors: Claims arising from the Lead Insurer's system errors or operational mistakes could prevent timely reimbursement for co-insurance entities, potentially leading to disputes and penalties.
- Withdrawal Risk: Any co-insurer unilaterally withdrawing from the consortium before fulfilling insurance liabilities would incur breach of contract liability, and their share would be proportionally assumed by remaining co-insurers.
Future Outlook
The agreement outlines a structured plan for the "[] Project" for the 2025 policy year, with specific participation rate targets (8% guaranteed, 10% targeted) based on a 32 million person base. It also mentions eligibility for participation in the "[] 2026" project, indicating an intention for continuation beyond 2025, contingent on performance (e.g., offline sales volume above 50,000 policies for co-insurers).
Management Comments
- "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report."
Industry Context
This agreement reflects a growing trend in China towards inclusive commercial health insurance, often supported by government initiatives and involving collaborations between traditional insurers and technology/brokerage platforms. These projects aim to supplement basic medical insurance, addressing out-of-pocket expenses and specific conditions, thereby expanding health coverage accessibility for a broad population. The involvement of multiple insurers in a co-insurance consortium is a common model for risk sharing in large-scale, government-backed programs, aligning with national health policy objectives.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compliance Enhancement | CEO Botao Ma and CFO Yuanwen Xia provided certifications (Sarbanes-Oxley Act Sections 302 and 906) affirming the accuracy of financial reporting and effectiveness of disclosure controls and internal control over financial reporting for the fiscal year ended June 30, 2025. | 2026-01-12 | Reinforces commitment to financial transparency and robust internal controls, crucial for investor confidence and regulatory adherence. |
Related Party Transactions
- Sunshine Insurance Brokerage (Shanghai) Co., Ltd., a subsidiary of Zhibao Technology Inc., is Party J in the cooperation agreement, providing insurance brokerage services to the consortium. This constitutes a related party transaction.
Stakeholder Impact
- Shareholders: Potential for increased revenue and market share for Zhibao Technology Inc. through its subsidiary's involvement in a large-scale, government-backed insurance project.
- Employees: Increased operational workload for sales, customer service, and technical teams within Sunshine Insurance Brokerage and potentially Zhibao Technology Inc. due to the project's demands.
- Customers (Insured Persons): Access to an inclusive commercial health insurance product with broad coverage, no age/health restrictions, and a standardized premium, supplementing basic medical insurance.
- Co-insurers: Shared risk and benefits from participating in a significant insurance scheme, with clear operational guidelines and a structured framework for collaboration.
- Regulatory Authorities: The project aims to implement government directives related to health insurance, indicating alignment with regulatory goals for expanding health coverage and consumer protection.
Next Steps
- The Lead Insurer will file underwriting responsibilities for the "[] Project" with relevant regulatory authorities.
- Consortium members will jointly undertake publicity and implementation activities for the insurance product.
- Party I (technical service provider) will develop and maintain the policy application and claims systems, ensuring Level 3 cybersecurity and traceability compliance.
- Party J (brokerage service provider) will provide client advisory, training, and promotional guidance to the consortium companies.
- Co-insurers are required to remit performance bonds and their respective shares of claims payments and other expenses as per the agreement's timelines.
- Co-insurers whose offline sales volume falls below 50,000 policies in 2025 will be ineligible to participate in the subsequent "[] 2026" project.
Key Dates
| Date | Description |
|---|---|
| 2024-11-20 | Start of enrolment period for the [] 2025 product. |
| 2024-11-25 | Date of the Cooperation Agreement between Sunshine Insurance Broker (Shanghai) Co., Ltd. and Key Insurer B. |
| 2025-01-01 | Start of the policy coverage period for the [] 2025 product. |
| 2025-03-31 | End of the enrolment period for the [] 2025 product. |
| 2025-06-30 | End of the fiscal year for Zhibao Technology Inc. covered by the Form 20-F/A. |
| 2025-12-31 | End of the policy coverage period for the [] 2025 product and validity end date for the Cooperation Agreement. |
| 2026-01-12 | Date of CEO and CFO certifications for the Form 20-F/A. |
| 2026-12-31 | Extended claims acceptance period for the [] 2025 project ends. |
Keywords
Inclusive Health Insurance, Insurance Brokerage, Co-insurance Consortium, China Insurance Market, SEC Filing, Zhibao Technology Inc., Sunshine Insurance Brokerage, Health Coverage, Financial Services, Regulatory Compliance, Risk Management, Digital Insurance Platform
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.